Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest use in PPOS protocol for ovarian stimulation in ovarian endometriosis
ChiCTR2500106228Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dienogest in endometrioma (2 arms), sponsored by West China Second University Hospital. Primary endpoint: Number of oocytes retrieved. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
dienogest
03
Conditions
endometrioma
Beyond the preview
Go deeper on ChiCTR2500106228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106228.